Ascent Bio uses AI to unravel biological networks, driving advancements in precision medicine and personalized healthcare. Her unique cross-disciplinary roles allow for a fusion of innovation from both medicine and engineering, fostering a collaborative environment where computational techniques can be seamlessly applied to complex biological problems. This integration accelerates breakthroughs in drug discovery, ultimately enhancing the design of novel therapies. Drug development pipelines across the pharma industry are hindered by an R&D bottleneck where drug candidates must go through a laborious and cyclical process to reach a suitable property profile. Ascent Bio is building an AI-based molecule design engine to remove this bottleneck and allow for more molecules with better property profiles to reach the clinic. Ascent Bio is headquartered in New Haven.